Year: 2025

COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs. Q3 2024. TORONTO, ONTARIO, Nov. 11, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (FINRA: CSCIF) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, today reported its financial and operating results for the third quarter ended September 30, 2025 and provided a corporate update regarding operational and strategic developments during the quarter. “Our focus in Q3 was to ensure the zero-based budgeting and restructuring plans we designed were executed successfully to establish our go forward cost structure,” said Anna Biehn, Chief Executive Officer of COSCIENS. “Management...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. HALIFAX, Nova Scotia, Nov. 11, 2025 (GLOBE NEWSWIRE) — GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) (“GoGold” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets (collectively the “Underwriters”), under which the Underwriters have agreed to buy on a bought deal basis 47,170,000 units (the “Units”), at a price of C$2.65 per Unit for gross proceeds of approximately C$125 million (the “Offering”). The offering is expected to close on or about November 27, 2025 and is subject to GoGold receiving all necessary regulatory approvals. Each Unit will be comprised of one common...

CHANTILLY, Va., Nov. 11, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a position on the $15 billion Pacific Deterrence Initiative Multiple Award Construction Contract (PDI MACC) by the Naval Facilities Engineering Systems Command (NAVFAC). The MACC consists of a 5-year base period with three one-year option periods and is a key component of the Pacific Deterrence Initiative, a U.S. Department of Defense program designed to strengthen deterrence capabilities, enhance regional security, and support the defense infrastructure throughout the Indo-Pacific region. Under the PDI MACC, Parsons will compete for task orders to provide design and engineering services to deliver projects exceeding $100 million in scope, including runways, hangars, waterfront facilities, warehousing and...

3D Systems’ SLA 825 Dual3D Systems’ SLA 825 Dual delivers unmatched surface finish, accuracy, and reliability for high performance industries such as transportation and motorsports, aerospace and defense, and service bureaus.ArrayCast Casting TreeArrayCast allows users to effortlessly create customized casting trees, complete with configurable runners, sprues, and end effectors tailored to their workflow.QuickCast pattern made with Accura SbFAccura SbF has no detectable Antimony, making it the perfect material for printing QuickCast patterns suitable for casting a variety of ferrous and non-ferrous high-performance metals.Vent made with Accura Xtreme BlackAccura Xtreme Black offers exceptional durability for challenging assemblies such as snap-fit components, rugged enclosures, and consumer electronics.SLA...

At Financial Analyst Day, AMD outlines long-term plan to expand data center and AI leadership with greater than 35% revenue CAGR and greater than $20 non-GAAP EPS target NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — Today at its Financial Analyst Day, AMD (NASDAQ: AMD) showcased its long-term strategy, leadership products and technology IP, underscoring the company’s momentum in driving accelerated growth and delivering long-term shareholder value. “AMD is entering a new era of growth fueled by our leadership technology roadmaps and accelerating AI momentum,” said Dr. Lisa Su, AMD chair and CEO. “With the broadest portfolio of products and our deepening strategic partnerships, AMD is uniquely positioned to lead the next generation of high-performance and AI computing. We see a tremendous opportunity ahead to deliver sustainable, industry-leading...

TULSA, Okla., Nov. 11, 2025 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) will participate in an investor conference this week and in a fireside chat session at 1:10 p.m. Eastern Time (12:10 p.m. Central Time) on Wednesday, Nov. 12. The session will be webcast live on ONEOK’s website at www.oneok.com. The webcast will also be available for replay. ONEOK’s latest investor materials are available at www.oneok.com. ——————————————————————————————————————- At ONEOK (NYSE: OKE), we deliver energy products and services vital to an advancing world. We are a leading midstream operator that provides gathering, processing,...

MILWAUKEE, Wis., Nov. 11, 2025 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management (“AUM”) as of October 31, 2025 totaled $182.6 billion. Artisan Funds and Artisan Global Funds accounted for $88.5 billion of total firm AUM, while separate accounts and other AUM1 accounted for $94.1 billion.PRELIMINARY ASSETS UNDER MANAGEMENT BY STRATEGY2         As of October 31, 2025 – ($ Millions)    Growth Team    Global Opportunities $19,747  Global Discovery   1,882  U.S. Mid-Cap Growth   11,149  U.S. Small-Cap Growth   2,988  Franchise   933  Global Equity Team    Global Equity   427  Non-U.S. Growth   15,421  U.S. Value Team    Value Equity   5,303  U.S. Mid-Cap Value   2,112  Value Income   17  International...

CUSA ClarityCUSA Clarity Ultrasonic Surgical Aspirator SystemPRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce the FDA 510(k) clearance for use of its CUSA® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeries, including valve replacement and repair. In addition to cardiac surgery, the CUSA Clarity Ultrasonic Surgical Aspirator System is indicated for use in surgical procedures where fragmentation, emulsification and aspiration of soft and hard (e.g. bone) tissue is desirable, such as neurosurgery, plastic and reconstructive surgery, orthopedic surgery, thoracic...